D.A. Davidson & Co. Chroma Dex Corp. Transaction History

D.A. Davidson & Co.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.02 - $3.92 $42,420 - $82,320	-21,000 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$3.74 - $6.7 $7,480 - $13,400	-2,000 Reduced 8.7%	21,000 $79,000
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.41 $6,050 - $10,410	-1,000 Reduced 4.17%	23,000 $144,000
Q1 2021 May 07, 2021	SELL	$4.59 - $18.74 $66,555 - $271,730	-14,500 Reduced 37.66%	24,000 $224,000
Q3 2020 Nov 02, 2020	BUY	$4.01 - $5.56 $6,015 - $8,340	1,500 Added 4.05%	38,500 $154,000
Q2 2020 Aug 10, 2020	BUY	$3.0 - $5.52 $6,000 - $11,040	2,000 Added 5.71%	37,000 $170,000
Q2 2019 Aug 13, 2019	SELL	$3.71 - $4.83 $37,100 - $48,300	-10,000 Reduced 22.22%	35,000 $163,000
Q2 2018 Aug 02, 2018	BUY	$3.22 - $4.43 $3,220 - $4,430	1,000 Added 2.27%	45,000 $167,000
Q4 2017 Feb 08, 2018	BUY	$3.88 - $6.96 $3,880 - $6,960	1,000 Added 2.33%	44,000 $259,000
Q3 2017 Nov 08, 2017	BUY	$2.91 - $4.71 $14,550 - $23,550	5,000 Added 13.16%	43,000 $184,000
Q2 2017 Aug 11, 2017	BUY	N/A	38,000	38,000 $0

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.